Artigos com autorizações de acesso público - Lamorde MSaiba mais
Não disponíveis em nenhum local: 5
Implementation of long-acting antiretroviral therapy in low-income and middle-income countries
FV Cresswell, M Lamorde
Current Opinion in HIV and AIDS 17 (3), 127-134, 2022
Autorizações: National Institute for Health Research, UK
Implementing routine physical function screening among elderly HIV-positive patients in Uganda
I Lwanga, MS Nabaggala, A Kiragga, A Calcagno, G Guaraldi, ...
AIDS care 32 (11), 1467-1470, 2020
Autorizações: US National Institutes of Health
Cost-Effectiveness of Dolutegravir Compared With Efavirenz for Prevention of Perinatal Transmission in Women Presenting With HIV in Late Pregnancy in Uganda
E Nuwamanya, SC Nassiwa, A Kuznik, C Waitt, T Malaba, L Myer, ...
Value in Health Regional Issues 44, 101017, 2024
Autorizações: World Health Organization
Unmet needs persist in pediatric HIV programs: lessons from selected case studies in Uganda
J Orikiiriza, J Nakawesi, B Kikaire, D Turitwenka, W Schlech, A Kambugu, ...
AIDS 31 (8), 1196-1199, 2017
Autorizações: Higher Education Authority, Ireland
Pregnancy outcomes for new ART regimens
M Lamorde, B Castelnuovo
The Lancet HIV 10 (5), e274-e275, 2023
Autorizações: US National Institutes of Health, European & Developing Countries Clinical …
Disponíveis em algum local: 108
Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial
K Kintu, TR Malaba, J Nakibuka, C Papamichael, A Colbers, K Byrne, ...
The lancet HIV 7 (5), e332-e339, 2020
Autorizações: US National Institutes of Health, World Health Organization
Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: a randomised trial (DolPHIN-1 study)
C Waitt, C Orrell, S Walimbwa, Y Singh, K Kintu, B Simmons, ...
PLoS medicine 16 (9), e1002895, 2019
Autorizações: UK Medical Research Council, Wellcome Trust
Unintended pregnancies observed with combined use of the levonorgestrel contraceptive implant and efavirenz-based antiretroviral therapy: a three-arm pharmacokinetic evaluation …
KK Scarsi, KM Darin, S Nakalema, DJ Back, P Byakika-Kibwika, LJ Else, ...
Clinical Infectious Diseases 62 (6), 675-682, 2016
Autorizações: US National Institutes of Health
Uganda’s experience in Ebola virus disease outbreak preparedness, 2018–2019
JR Aceng, AR Ario, AN Muruta, I Makumbi, M Nanyunja, I Komakech, ...
Globalization and health 16, 1-12, 2020
Autorizações: US Agency for International Development, Department of International …
Antenatal syphilis screening using point-of-care testing in Sub-Saharan African countries: a cost-effectiveness analysis
A Kuznik, M Lamorde, A Nyabigambo, YC Manabe
PLoS medicine 10 (11), e1001545, 2013
Autorizações: US National Institutes of Health
Optimizing antimicrobial use: challenges, advances and opportunities
TM Rawson, RC Wilson, D O’Hare, P Herrero, A Kambugu, M Lamorde, ...
Nature Reviews Microbiology 19 (12), 747-758, 2021
Autorizações: National Institute for Health Research, UK, Wellcome Trust
Traditional herbal medicine use associated with liver fibrosis in rural Rakai, Uganda
BJ Auerbach, SJ Reynolds, M Lamorde, C Merry, C Kukunda-Byobona, ...
PLoS One 7 (11), e41737, 2012
Autorizações: US National Institutes of Health
Estimating the public health burden associated with adverse pregnancy outcomes resulting from syphilis infection across 43 countries in sub-Saharan Africa
A Kuznik, AG Habib, YC Manabe, M Lamorde
Sexually transmitted diseases 42 (7), 369-375, 2015
Autorizações: US National Institutes of Health
Cost effectiveness of a pharmacy-only refill program in a large urban HIV/AIDS clinic in Uganda
JB Babigumira, B Castelnuovo, A Stergachis, A Kiragga, P Shaefer, ...
Plos one 6 (3), e18193, 2011
Autorizações: US National Institutes of Health
Drug–drug interactions, effectiveness, and safety of hormonal contraceptives in women living with HIV
KK Scarsi, KM Darin, CA Chappell, SM Nitz, M Lamorde
Drug safety 39 (11), 1053-1072, 2016
Autorizações: US National Institutes of Health
Antimicrobial drug resistance in blood culture isolates at a tertiary hospital, Uganda
H Kajumbula, AW Fujita, O Mbabazi, C Najjuka, C Izale, A Akampurira, ...
Emerging infectious diseases 24 (1), 174, 2018
Autorizações: US National Institutes of Health, Doris Duke Charitable Foundation
Artemether‐lumefantrine co‐administration with antiretrovirals: population pharmacokinetics and dosing implications
RM Hoglund, P Byakika‐Kibwika, M Lamorde, C Merry, M Ashton, ...
British journal of clinical pharmacology 79 (4), 636-649, 2015
Autorizações: Health Research Board, Ireland, Wellcome Trust
Potential impact of task-shifting on costs of antiretroviral therapy and physician supply in Uganda
JB Babigumira, B Castelnuovo, M Lamorde, A Kambugu, A Stergachis, ...
BMC health services research 9, 1-6, 2009
Autorizações: US National Institutes of Health
Delayed sputum culture conversion in tuberculosis–human immunodeficiency virus–coinfected patients with low isoniazid and rifampicin concentrations
C Sekaggya-Wiltshire, A Von Braun, M Lamorde, B Ledergerber, ...
Clinical Infectious Diseases 67 (5), 708-716, 2018
Autorizações: US National Institutes of Health
Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother–infant pairs
C Waitt, A Olagunju, S Nakalema, I Kyohaire, A Owen, M Lamorde, ...
Journal of Antimicrobial Chemotherapy 73 (4), 1013-1019, 2018
Autorizações: UK Medical Research Council, Wellcome Trust
As informações de publicação e financiamento são determinadas automaticamente por um programa informático.